scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S1054-3589(05)53013-8 |
P698 | PubMed publication ID | 17239771 |
P2093 | author name string | Nikos K Karamanos | |
A D Theocharis | |||
G N Tzanakakis | |||
I Tsolakis | |||
P2860 | cites work | Versican interacts with chemokines and modulates cellular responses | Q28138079 |
Characterization of heparin affin regulatory peptide signaling in human endothelial cells | Q28242363 | ||
Midkine and pleiotrophin in neural development and cancer | Q28249687 | ||
Proteoglycans in atherosclerosis and restenosis: key roles for versican | Q28261672 | ||
Matrix proteoglycans: from molecular design to cellular function | Q28284300 | ||
Negative regulation of transforming growth factor-beta by the proteoglycan decorin | Q28292224 | ||
High-performance capillary electrophoretic analysis of hyaluronan and galactosaminoglycan-disaccharides in gastrointestinal carcinomas. Differential disaccharide composition as a possible tool-indicator for malignancies | Q31039421 | ||
Human abdominal aortic aneurysm is characterized by decreased versican concentration and specific downregulation of versican isoform V(0). | Q31886397 | ||
Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate | Q34216561 | ||
Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate | Q34271235 | ||
Retrovirally mediated overexpression of versican v3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients | Q34286189 | ||
Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. | Q34706643 | ||
Versican: a versatile extracellular matrix proteoglycan in cell biology | Q34858300 | ||
Extracellular matrix in vascular morphogenesis and disease: structure versus signal | Q35024836 | ||
The role of proteoglycans in cell adhesion, migration and proliferation | Q35455376 | ||
Involvement of stromal proteoglycans in tumour progression | Q35703715 | ||
Proteoglycans: structures and interactions | Q37285263 | ||
Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding | Q37383221 | ||
Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines | Q38292486 | ||
Identification of the proteoglycan binding site in apolipoprotein B48. | Q40724243 | ||
Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. | Q40860247 | ||
Identification and characterization of ligands for L-selectin in the kidney. I. Versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectin | Q40957934 | ||
Specificity of the low density lipoprotein-glycosaminoglycan interaction | Q43603450 | ||
Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. | Q43864458 | ||
Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors | Q43909337 | ||
Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues | Q44131360 | ||
Decreased biglycan expression and differential decorin localization in human abdominal aortic aneurysms | Q44205488 | ||
Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma | Q44280557 | ||
Matrix proteoglycans are markedly affected in advanced laryngeal squamous cell carcinoma | Q47345541 | ||
The Proteoglycan Decorin Links Low Density Lipoproteins with Collagen Type I | Q62023755 | ||
Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL | Q72689994 | ||
Human abdominal aortic aneurysm is closely associated with compositional and specific structural modifications at the glycosaminoglycan level | Q72996241 | ||
Chondroitin 4-sulphate exhibits inhibitory effect during Cu2+-mediated LDL oxidation | Q73094739 | ||
Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition | Q73098910 | ||
Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain | Q73119221 | ||
Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis | Q77124466 | ||
Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury | Q77743543 | ||
CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-gamma and some of its biological effects on human vascular smooth muscle cells | Q77926846 | ||
Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin | Q78390022 | ||
Compositional and structural alterations of chondroitin and dermatan sulfates during the progression of atherosclerosis and aneurysmal dilatation of the human abdominal aorta | Q78578854 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 281-295 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Advances in Pharmacology | Q15753809 |
P1476 | title | Chondroitin sulfate as a key molecule in the development of atherosclerosis and cancer progression | |
P478 | volume | 53 |
Q28828562 | "On-The-Spot" Arresting of Chondroitin Sulphate Proteoglycans: Implications for Ovarian Adenocarcinoma Recognition and Intervention |
Q40007453 | Association between Human Plasma Chondroitin Sulfate Isomers and Carotid Atherosclerotic Plaques |
Q54096113 | Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer. |
Q35131282 | Biphasic role of chondroitin sulfate in cardiac differentiation of embryonic stem cells through inhibition of Wnt/β-catenin signaling |
Q38725258 | Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration |
Q37282934 | Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer. |
Q36960622 | Chondroitin Sulfate in Solution: Effects of Mono- and Divalent Salts |
Q39950503 | Chondroitin sulphate-modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas-mediated pathway. |
Q38260546 | Chondroitinase: A promising therapeutic enzyme |
Q35894756 | Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma |
Q36736328 | Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis |
Q90706035 | Four targeted genes for predicting the prognosis of colorectal cancer: A bioinformatics analysis case |
Q64249445 | Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation |
Q37983930 | Glycosaminoglycans: key players in cancer cell biology and treatment |
Q36730629 | Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo |
Q33724421 | Monitoring serum chondroitin sulfate levels in patients submitted to coronary artery bypass surgery. |
Q37470684 | Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility. |
Q34456785 | Primary ovarian carcinomas and abdominal metastasis contain 4,6-disulfated chondroitin sulfate rich regions, which provide adhesive properties to tumour cells |
Q35036132 | Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells |
Q37467048 | Serglycin: at the crossroad of inflammation and malignancy |
Q39875693 | Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells |
Q64951034 | Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy. |
Q36212978 | Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody. |
Q37784307 | The Roles of Chondroitin-4-Sulfotransferase-1 in Development and Disease |
Q36853007 | Upregulation of decorin by FXR in vascular smooth muscle cells |
Search more.